P866: CORRELATIVE ANALYSIS TO DEFINE PATIENT PROFILES ASSOCIATED WITH MANUFACTURING AND CLINICAL ENDPOINTS IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED WITH IDECABTAGENE VICLEUCEL (BB2121)

• J. Rytlewski,
• J. Fuller,
• D. R. Mertz,
• C. Freeman,
• S. Manier,
• N. Shah,
• T. B. Campbell

Affiliations

J. Rytlewski

1 Bristol Myers Squibb, Princeton, NJ

J. Fuller

1 Bristol Myers Squibb, Princeton, NJ

D. R. Mertz

1 Bristol Myers Squibb, Princeton, NJ

C. Freeman

2 Moffitt Cancer Center, Tampa, FL, United States of America

S. Manier

3 CHU de Lille, University of Lille, Lille, France

N. Shah

4 University of California San Francisco, San Francisco, CA, United States of America

T. B. Campbell

1 Bristol Myers Squibb, Princeton, NJ